Association between adipokines and critical illness outcomes
Authors:
- Tahar HajriTahar Hajri
- Mohamed GharibMGMohamed Gharib
- Sanjeev KaulSKSanjeev Kaul
- Martin S. KarpehMKMartin S. Karpeh
- 1 September 2017
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 83 (3) , 507-519
Abstract
Adipose tissue is an endocrine organ that plays a critical role in immunity and metabolism by virtue of a large number of hormones and cytokines, collectively termed adipokines. Dysregulation of adipokines has been linked to the pathogenesis of multiple diseases, but some questions have arisen concerning the value of adipokines in critical illness setting. The objective of this review was to evaluate the associations between blood adipokines and critical illness outcomes. PubMed, CINAHL, Scopus and the Cochrane Library databases were searched from inception through July 2016 without language restriction. Studies reporting the associations of adipokines, leptin, adiponectin, resistin and/or visfatin with critical illness outcomes mortality, organ dysfunction and/or inflammation were included. A total of 38 articles were selected according to the inclusion/exclusion criteria of the study. Significant alterations of circulating adipokines have been reported in critically ill patients, some of which were indicative of patient outcomes. The associations of leptin and adiponectin with critical illness outcomes were not conclusive, in that blood levels of both adipokines did not always correlate with the illness severity scores or risks of organ failure and mortality. By contrast, studies consistently reported striking increase of blood resistin and visfatin, independently of the critical illness etiology. More interestingly, increased levels of these adipokines were systematically associated with severe inflammation, and high incidence of organ failure and mortality. CONCLUSIONS AND LEVEL OF EVIDENCE There is strong evidence to indicate that increased levels of blood resistin and visfatin are associated with poor outcomes of critically ill patients, including higher inflammation, and greater risk of organ dysfunction and mortality. Systematic review, level IIIKeywords
This publication has 79 references indexed in Scilit:
- Regulation of adiponectin production by insulin: interactions with tumor necrosis factor-α and interleukin-6American Journal of Physiology-Endocrinology and Metabolism, 2011
- Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patientsBMC Surgery, 2010
- Relevance of Serum Leptin and Leptin-Receptor Concentrations in Critically Ill PatientsMediators of Inflammation, 2010
- Changes in peroxisome proliferator-activated receptor-gamma activity in children with septic shockIntensive Care Medicine, 2009
- Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patientsCritical Care, 2009
- Lung injury after hemorrhage is age dependent: Role of peroxisome proliferator-activated receptor γ*Critical Care Medicine, 2009
- Plasma leptin and insulin-like growth factor I levels during acute exacerbations of chronic obstructive pulmonary diseaseBMC Pulmonary Medicine, 2009
- Essential Role of Pre–B-Cell Colony Enhancing Factor in Ventilator-induced Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Adipocyte, Adipose Tissue, and Infectious DiseaseInfection and Immunity, 2007
- Adipocytokines: mediators linking adipose tissue, inflammation and immunityNature Reviews Immunology, 2006